| Sample | Title | Value | Rank |
|---|
| GSM780707 | Untreated after 4 days (C1_1) | 49.7978 | 48 |
| GSM780708 | Untreated after 4 days (C2_1) | 44.7308 | 26 |
| GSM780709 | Untreated after 4 days (C3_1) | 50.5194 | 50 |
| GSM780719 | Untreated after 4 days (C1_2) | 51.567 | 53 |
| GSM780720 | Untreated after 4 days (C2_2) | 47.3638 | 38 |
| GSM780721 | Untreated after 4 days (C3_2) | 45.3994 | 29 |
| GSM780710 | Trastuzumab treated after 4 days (T1_1) | 46.8957 | 36 |
| GSM780711 | Trastuzumab treated after 4 days (T2_1) | 44.6136 | 25 |
| GSM780712 | Trastuzumab treated after 4 days (T3_1) | 47.1026 | 37 |
| GSM780722 | Trastuzumab treated after 4 days (T1_2) | 50.2631 | 49 |
| GSM780723 | Trastuzumab treated after 4 days (T2_2) | 45.2545 | 28 |
| GSM780724 | Trastuzumab treated after 4 days (T3_2) | 43.2235 | 18 |
| GSM780713 | Pertuzumab treated after 4 days (P1_1) | 45.917 | 32 |
| GSM780714 | Pertuzumab treated after 4 days (P2_1) | 47.5666 | 39 |
| GSM780715 | Pertuzumab treated after 4 days (P3_1) | 44.9854 | 27 |
| GSM780725 | Pertuzumab treated after 4 days (P1_2) | 47.7857 | 40 |
| GSM780726 | Pertuzumab treated after 4 days (P2_2) | 46.4993 | 34 |
| GSM780727 | Pertuzumab treated after 4 days (P3_2) | 47.3384 | 38 |
| GSM780716 | Trastuzumab and Pertuzumab treated after 4 days (TP1_1) | 52.7099 | 56 |
| GSM780717 | Trastuzumab and Pertuzumab treated after 4 days (TP2_1) | 47.5016 | 39 |
| GSM780718 | Trastuzumab and Pertuzumab treated after 4 days (TP3_1) | 44.0188 | 22 |
| GSM780728 | Trastuzumab and Pertuzumab treated after 4 days (TP1_2) | 46.2705 | 33 |
| GSM780729 | Trastuzumab and Pertuzumab treated after 4 days (TP2_2) | 44.7736 | 26 |